IP Verse

Inserm (institut National De La Santé Et De La Recherche Médicale) competitive analysis

Latest patents of Inserm (institut National De La Santé Et De La Recherche Médicale) opposed by its competitors

Explore Inserm (institut National De La Santé Et De La Recherche Médicale)'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3019610
Mar 19, 2025Methods For Performing Antisense Oligonucleotide-Mediated Exon Skipping In The Retina Of A Subject In Need Thereof2
EP3752134
Dec 4, 2024Methods And Compositions For Treating Vitiligo1
EP3911354
Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin Gene5
EP3066203
Nov 8, 2023New Alzheimer'S Disease Animal Model1
EP3995507
Oct 4, 2023Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines1
EP3768304
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins8
EP3059307
May 4, 2022Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells1
EP3320101
Aug 11, 2021Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject1
EP3443979
May 27, 2020Il-2 Dosage Regimen For Treating Systemic Lupus Erythematosus1
EP2683395
Aug 1, 2018Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders1

Latest PTAB cases involving Inserm (institut National De La Santé Et De La Recherche Médicale)

Discover the latest PTAB cases involving Inserm (institut National De La Santé Et De La Recherche Médicale), highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Inserm (institut National De La Santé Et De La Recherche Médicale) with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE - 40 - -
MICHALSKI HTTERMANN & PARTNER26 - - -
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB30 - - -
STRAWMAN384 - - -